Ligand validation:4FJI

DCP: 2'-DEOXYCYTIDINE-5'-TRIPHOSPHATE

DCP is a Ligand Of Interest in 4FJI designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
4FJI_DCP_A_1001	79%	53%	0.139	0.986	1.05	0.77	2	-	1	0	100%	1
3QEV_DCP_A_904	90%	57%	0.103	0.986	0.8	0.85	-	-	0	0	100%	1
4DTS_DCP_A_1001	88%	51%	0.11	0.987	0.86	1.04	1	1	1	0	100%	1
3QEI_DCP_A_904	87%	57%	0.107	0.979	0.87	0.8	1	-	0	0	100%	1
3NCI_DCP_A_904	83%	55%	0.122	0.981	0.87	0.87	1	2	0	0	100%	1
4FJ8_DCP_A_1001	82%	55%	0.131	0.986	0.92	0.84	1	3	1	0	100%	1
3IAY_DCP_A_986	99%	51%	0.058	0.986	0.9	0.98	1	2	2	0	100%	1
4YR0_DCP_A_501	98%	55%	0.067	0.986	0.83	0.91	1	2	0	0	100%	1
2HVW_DCP_C_1203	97%	53%	0.062	0.977	0.86	0.95	1	1	0	0	100%	1
4RZR_DCP_D_401	97%	47%	0.069	0.984	0.84	1.19	-	3	0	0	100%	1
7RBH_DCP_A_402	97%	57%	0.069	0.983	0.83	0.81	1	1	0	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.